Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Other financing activities (2016 - 2025)

Historic Other financing activities for Cartesian Therapeutics (RNAC) over the last 6 years, with Q3 2025 value amounting to $43000.0.

  • Cartesian Therapeutics' Other financing activities changed N/A to $43000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $588000.0, marking a year-over-year change of. This contributed to the annual value of $66000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Cartesian Therapeutics' Other financing activities stood at $43000.0.
  • Cartesian Therapeutics' Other financing activities' 5-year high stood at $454000.0 during Q1 2025, with a 5-year trough of $25000.0 in Q2 2025.
  • Moreover, its 3-year median value for Other financing activities was $66000.0 (2024), whereas its average is $139600.0.